Pep Guardiola Moves Quickly Amid Injury Crisis to Josko Gvardiol and Ruben Dias.

Max Alleyne Manchester City recall

Manchester City have acted swiftly to bolster their defensive options by recalling promising young centre-back Max Alleyne from his season-long loan at Championship side Watford, with the move taking immediate effect on January 5, 2026.

The decision comes in response to a growing injury crisis at the heart of City’s defence. Star defender Josko Gvardiol suffered a painful right leg/ankle injury during the 1-1 draw against Chelsea on January 4, forcing him off early in the second half. Manager Pep Guardiola later confirmed concerns, stating the issue “doesn’t look good” and suggesting Gvardiol could be sidelined for several weeks.

Compounding the problem, Ruben Dias also picked up a muscular injury in the same match, with Guardiola noting similar worries. John Stones remains out long-term, leaving City short on experienced centre-backs.

The 20-year-old Alleyne, a product of City’s academy, has impressed during his time at Watford. He made 16-17 Championship appearances, starting regularly in recent weeks and contributing to a strong defensive record, including several clean sheets. City officials were reportedly “very happy” with his development and game time at Vicarage Road.

Alleyne, who signed a new long-term contract with City before his loan move, is expected to join the first-team squad immediately. Reports suggest he could feature in upcoming matches, including against Brighton in the Premier League and potentially starting in the FA Cup tie versus Exeter.

This pragmatic recall provides short-term cover without disrupting other loans, as City have no plans to bring back additional defenders currently out on loan.

The move is a blow to Watford, who were surprised by the decision and have climbed into the playoff places partly thanks to Alleyne’s contributions alongside Mattie Pollock.

As Manchester City navigate a busy January schedule, all eyes will be on Alleyne’s integration and updates on the recovery timelines for Gvardiol and Dias.